TNF and heart failure: Pentoxifylline and thalidomide have both been shown to reduce TNF production as well as other pro-inflammatory mediators and in several small clinical trials have demonstrated a capacity to improve LVEF and symptoms in patients with heart failure [84,85] though not mortality.